Nycomed’s Q3 undermined by pantoprazole decline

November 11, 2010
Sales and Marketing Daxas, Guangdong Techpool Bio-Pharma, Nycomed, Protium, pantoprazole

Nycomed has seen its sales inch downwards in the third quarter, as the decline of its biggest seller pantoprazole continued. …

Pfizer enters drug repositioning collaboration with Biovista

November 11, 2010
Research and Development Biovista, FDA, Neurontin, Pfizer, Pfizer Indications Discovery Unit, drug repositioning, viagra

Pfizer has signed a pilot research agreement with drug repositioning specialist Biovista. The aim of the collaboration is to identify …

Patients in UK cancer trials quadruples

November 11, 2010
Research and Development Cancer Research UK, NCRI, National Cancer Research Institute, UK clinical research, cancer trials

The number of cancer patients in the UK participating in clinical studies has quadrupled in the last decade, according to …

Novartis drops late stage lung cancer candidate

November 11, 2010
Research and Development ASA404, Antisoma, NSCLC, Novartis, cancer research, lung cancer, non small cell lung cancer, non-small cell lung cancer

Novartis has discontinued phase III trials for its lung cancer candidate ASA404 after it once again failed to meet its …

Digital for digital’s sake is out

November 10, 2010
Medical Communications digital creativity, digital marketing, ipad, seven stones, youtube

Creativity in the digital world is twofold. On the one hand there is technical wizardry and, on the other, there …

RSA expands global team

November 10, 2010
Business Services Matthew Edwards, Michelle Bosshard, Yildiz Biloglu, Zaki Sellam, appointment, business services, rsa

Life sciences executive search and interim management company RSA has made a number of appointments and internal promotions across its …

Sanofi’s C diff vaccine fast tracked by FDA

November 10, 2010
Research and Development C diff, C diff vaccine, C difficile, Clostridium difficile, FDA, FDA fast-track, Sanofi, Sanofi Pasteur

A new vaccine aimed at preventing C difficile infections has been fast tracked by the FDA. The regulator’s decision signals …

Genzyme again snubs suitor Sanofi

November 10, 2010
Research and Development, Sales and Marketing Campath, Chris Viehbacher, Genzyme, Henri Termeer, Orphan Drugs, Plavix, Sanofi, Sanofi-Aventis, manufacturing compliance

Genzyme has once again snubbed Sanofi-Aventis as the French pharma firm continues its pursuit of the beleaguered biotech company. Henri …

Bayer rebrands pharma division

November 10, 2010
Medical Communications, Sales and Marketing Bayer Healthcare, Bayer cross, Byaer Schering Pharma, Marijn Dekkers, Xarelto, prix galien

The name Bayer Schering Pharma has been consigned to the corporate dustbin as its parent group institutes a branding shake-up. …

NICE limits access to cancer drugs, study confirms

November 10, 2010
Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, Cancer Drugs Fund, IPSOR, Maximilian Lebmeier, NICE, hta

NICE became more restrictive in its assessment of new cancer drugs between 2007 and 2009, a new report suggests. The …

Pfizer and Boehringer's COPD campaign website

Pfizer and Boehringer pilot COPD campaign

November 9, 2010
Medical Communications Boehringer Ingelheim, COPD, Pfizer, Salford, chronic bronchitis, chronic obstructive pulmonary disease, emphysema

Pfizer and Boehringer Ingelheim have mobilised a soap opera star, painted rugby players and a special ‘breathing bus’ for a …

Blog footer

Digital Pharma: Online health information reduces costs

November 9, 2010
Medical Communications Digital Pharma blog, Football Fan Fitness Challenge, NHS Choices, alcohol tracker iPhone app, online health information, patient information

The number of people using the official NHS website rose 10% in the last year, making it the most popular …

Improving Clinical Site Productivity

November 9, 2010
Sales and Marketing Kinapse, White paper

There are a number of factors in the industry that make clinical trials more costly, more time-consuming and requiring more …

Lilly headquarters

Lilly bolsters diagnostics presence with Avid acquisition

November 9, 2010
Research and Development Alzheimer's disease, Alzheimer’s disease, Avid Radiopharma, Eli Lilly, diabetes, emagacestat, florbetapir, lilly

Eli Lilly has acquired specialist diagnostics firm Avid Radiopharma in a deal that will bolster its diagnostics business. Philadelphia-based Avid …

Novartis signs Middle East vaccine production deal

November 9, 2010
Manufacturing and Production Agrippal, Arabio, Novartis, Quinvaxem, meningitis vaccine Menveo, vaccines

Novartis has forged an alliance with a Saudi Arabian manufacturer to help it expand its vaccines business in the Middle …

Cambrex buys Zenara to enter nicotine replacement market

November 9, 2010
API, Cambrex, Cambrex Zenara, India, Pharmaceutical ingredients, Zenara Pharma, generic APIs, nicotine replacement

Pharmaceutical ingredient manufacturer Cambrex has taken a majority stake in Indian formulator Zenara Pharma for $20 million in a move …

Pharma manufacturing news in brief

November 9, 2010
Manufacturing and Production Genentech, Hovione, Jacobs Engineering, Laureate Pharma, Recipharm, contract manufacturing, pharma manufacturing

Hovione wins a patent dispute, Genentech is awarded for a manufacturing plant and there are new contracts for Recipharm, Jacobs …

Late stage trial boost for Pfizer’s arthritis drug tasocitinib

November 8, 2010
JAK inhibitors, Pfizer, arthritis, tasocitinib

Pfizer’s rheumatoid arthritis treatment tasocitinib has met its two of its three primary endpoints in a phase III trial. Primary …

Trial failure for Merck Serono’s Parkinson’s candidate

November 8, 2010
Research and Development Merck Serono, Newron Pharmaceuticals, Parkinson's disease, dopamine agonists, levodopa, safinamide

Merck Serono’s new alpha-aminoamide safinamide has failed to reach its primary endpoint in a study with Parkinson’s disease patients. Merck …

Recycling pharma marketing research

November 8, 2010
Medical Communications, Sales and Marketing Insight Marketing Systems, market research, marketing research, pharma marketing research

Recycling is in vogue. Not just in the consumer market, but across business sectors too. But recycling in the market …

The Gateway to Local Adoption Series

Latest content